...
首页> 外文期刊>Journal of cellular and molecular medicine. >Activation of ATP‐sensitive potassium channels facilitates the function of human endothelial colony‐forming cells via Ca2+/Akt/eNOS pathway
【24h】

Activation of ATP‐sensitive potassium channels facilitates the function of human endothelial colony‐forming cells via Ca2+/Akt/eNOS pathway

机译:ATP敏感性钾通道的激活通过Ca2 + / Akt / eNOS途径促进人类内皮集落形成细胞的功能

获取原文
           

摘要

Abstract Accumulating data, including those from our laboratory, have shown that the opening of ATP-sensitive potassium channels (KATP) plays a protective role in pulmonary vascular diseases (PVD). As maintainers of the endothelial framework, endothelial colony-forming cells (ECFCs) are considered excellent candidates for vascular regeneration in cases of PVD. Although KATP openers (KCOs) have been demonstrated to have beneficial effects on endothelial cells, the impact of KATP on ECFC function remains unclear. Herein, this study investigated whether there is a distribution of KATP in ECFCs and what role KATP play in ECFC modulation. By human ECFCs isolated from adult peripheral blood, KATP were confirmed for the first time to express in ECFCs, comprised subunits of Kir (Kir6.1, Kir6.2) and SUR2b. KCOs such as the classical agent nicorandil (Nico) and the novel agent iptakalim (Ipt) notably improved the function of ECFCs, promoting cell proliferation, migration and angiogenesis, which were abolished by a non-selective KATP blocker glibenclamide (Gli). To determine the underlying mechanisms, we investigated the impacts of KCOs on CaMKII, Akt and endothelial nitric oxide synthase pathways. Enhanced levels were detected by western blotting, which were abrogated by Gli. This suggested an involvement of Ca2+ signalling in the regulation of ECFCs by KATP. Our findings demonstrated for the first time that there is a distribution of KATP in ECFCs and KATP play a vital role in ECFC function. The present work highlighted a novel profile of KATP as a potential target for ECFC modulation, which may hold the key to the treatment of PVD.
机译:摘要包括我们实验室在内的大量数据表明,ATP敏感性钾通道(K ATP )的开放在肺血管疾病(PVD)中起保护作用。作为内皮框架的维持者,在PVD病例中,内皮集落形成细胞(ECFC)被认为是血管再生的极佳候选者。尽管已证明K ATP 开启剂(KCO)对内皮细胞有有益作用,但K ATP 对ECFC功能的影响尚不清楚。在此,本研究调查了ECFC中是否存在K ATP 的分布以及K ATP 在ECFC调制中的作用。通过从成人外周血中分离出的人类ECFC,首次确认了K ATP 在ECFC中表达,其包含Kir的亚基(Kir6.1,Kir6.2)和SUR2b。 KCO,例如经典药物nicorandil(Nico)和新型药物iptakalim(Ipt)显着改善了ECFC的功能,促进了细胞增殖,迁移和血管生成,但非选择性K ATP 废除了阻断剂格列本脲(Gli)。为了确定潜在的机制,我们调查了KCO对CaMKII,Akt和内皮型一氧化氮合酶途径的影响。通过Western印迹检测到增强的水平,通过Gli废止。这提示Ca 2 + 信号参与了K ATP 对ECFC的调控。我们的发现首次证明ECFC中存在K ATP 的分布,而K ATP 在ECFC功能中起着至关重要的作用。目前的工作强调了K ATP 作为ECFC调节潜在靶标的新颖概况,这可能是治疗PVD的关键。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号